Bart Crielaard, MD-PhD
I was a postdoctoral associate in the Rivella lab between 2012 and 2014. Originally trained as an MD with a scientific background in targeted drug delivery, I joined the Rivella lab to work on the role of macrophages in erythropoiesis and iron metabolism. I was specifically interested in identifying molecular leads that play an essential role in the interaction between macrophage and erythroid cells, allowing for the development of novel therapies for red blood cell disorders. Currently, I’m working as an assistant professor at the University of Groningen, The Netherlands, where I head my own research group that focuses on the development of bio- and nanomaterials for clinical applications. Part of our research focuses on designing new therapies that exploit iron metabolism for various diseases, such as cancer.